articleNavigating the regulatory challenge of PFAS for pharmaceutical manufacturers10 April 2025 | By Courtney Soulsby (BSI)Courtney Soulsby, Sector Development Director, Healthcare at the British Standards Institute, reveals how the industry can prepare for PFAS regulations now to get ahead of the curve.
newsNew WHO guidance to support manufacturers to reduce AMR risk4 September 2024 | By Catherine Eckford (European Pharmaceutical Review)The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging.
newsPharma unites to secure renewable energy in key manufacturing markets29 November 2023 | By Catherine Eckford (European Pharmaceutical Review)The new industry collaboration aims to help decarbonise the global supply chain by focusing on the energy-intensive pharmaceutical manufacturing that takes place in China and India.
newsSandoz and Teva achieve first-of-a-kind manufacturing certification9 November 2023 | By Catherine Eckford (European Pharmaceutical Review)In their commitment to tackling global antimicrobial resistance (AMR), the first two Pharma companies have gained independent certification in responsible antibiotic manufacturing.
articleAMR certification: recognising responsibly in antibiotic manufacture22 June 2023 | By Catherine Eckford (European Pharmaceutical Review)Following the recent launch of the BSI’s AMR certification, EPR invited Steve Brooks from the AMR Industry Alliance and BSI’s Courtney Soulsby to elucidate its significance for antibiotic manufacturers and the wider pharma industry.
